David Wise, MD PhD
About David Wise, MD PhD
David Wise, MD PhD, is the Director of Genitourinary Medical Oncology at NYU Langone Health, specializing in advanced prostate cancer therapeutics and urologic cancers.
Current Role at NYU Langone Health
David Wise, MD PhD, currently serves as the Director of Genitourinary Medical Oncology at NYU Langone Health. He began this role in 2022 and is responsible for overseeing clinical trials and treatments related to urologic cancers, with a particular focus on advanced prostate cancer. His work is centered in New York, New York, where he leads a team dedicated to developing innovative therapeutic strategies.
Previous Position at NYU Langone Health
Before becoming the Director of Genitourinary Medical Oncology, David Wise worked at NYU Langone Health as a Prostate Cancer Medical Oncologist from 2017 to 2022. During his five-year tenure, he specialized in clinical trials and the development of new treatments for prostate cancer, contributing significantly to the advancement of therapies in this field.
Post-Doctoral Fellowship at Memorial Sloan Kettering Cancer Center
David Wise completed a post-doctoral fellowship at the Laboratory of Charles Sawyers from 2014 to 2017, within the Human Oncology and Pathogenesis Program at Memorial Sloan Kettering Cancer Center. His research during this period focused on preclinical platforms for drug development, particularly in prostate cancer, where he worked on innovative approaches to fast-track new therapeutic options.
Medical Oncology Fellowship
From 2013 to 2017, David Wise was a Medical Oncology Fellow at Memorial Sloan Kettering Cancer Center. This fellowship provided him with extensive training and experience in the field of medical oncology, allowing him to gain expertise in treating various types of cancer, particularly urologic cancers.
Education and Training
David Wise holds an MD PhD in Cell Biology from the University of Pennsylvania School of Medicine, where he studied from 2004 to 2011. He also completed his BA in Biology and Chemistry at Yeshiva University from 2001 to 2004. His educational background laid a strong foundation for his career in oncology, equipping him with the knowledge and skills necessary for his research and clinical practice.